Raymond James authorized repurchase of the company’s shares of common stock in an aggregate amount of up to $1.5B. The $1.5B authorization replaces the previous repurchase authorization of $1.5B announced on December 1, 2022, under which approximately $700M was remaining as of November 30, 2023. The Board’s authorization does not have a fixed expiration date.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RJF: